filmov
tv
Updates in Treatment Using ADT and Anti-Androgens
Показать описание
E. David Crawford, MD, discusses ADT and anti-androgens and where they currently stand as prostate cancer treatment methods.
0:10:38
Updates in Treatment Using ADT and Anti-Androgens
0:13:09
Updates in ADT: Managing Adverse Effects
0:11:18
Updates on the ARANOTE Trial: PSA Response with Darolutamide Plus ADT in Patients with mHSPC
0:27:50
New Concepts in ADT
0:04:05
ADT and Its Consequences in the Treatment of Prostate Cancer
0:14:06
Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRI
0:04:09
Prostate Cancer BREAKTHROUGH: New ADT Treatments Update 2025!
0:09:30
Functional Pharmacist Analyzes Ivermectin: 2024 Update
1:27:03
Mission Possible in Prostate Cancer
0:59:31
Prostate Cancer in 2024: Recent Updates and Treatment Advances
0:01:38
5-year follow up of short-course abiraterone and ADT for high-risk prostate cancer
0:02:27
Prognostic impact of PSA thresholds in mHSPC after ADT-ARPI
0:10:36
Triplet Therapy vs. ADT: Choosing the Right Approach for Metastatic Prostate Cancer
0:03:28
Updates on ADT as monotherapy for management of mHSPC
0:02:52
What Is ADT For Prostate Cancer? - Oncology Support Network
0:00:29
The Role of ADT in Prostate Cancer Recurrence
0:01:23
What are the advantages of ADT transdermal patches for prostate cancer?
0:30:48
Hormone Therapy & Advanced Therapies for Prostate Cancer, Celestia Higano, MD | 2021 Mid-Year Up...
0:05:34
Addressing Bone Loss and the Lingering Use of ADT Monotherapy
0:20:32
Prostate Cancer Treatment update 2021
0:04:32
Impact of Androgen Deprivation Therapy (ADT) on Sexual Function
0:01:19
An AI biomarker to aid in the decision of treatment with ADT for localized prostate cancer
1:33:13
Dr Richard Lam, IPCSG November 2019 ADT, The latest updates
0:00:40
PERSIAN: early results of SBRT with apalutamide and ADT in mHSPC
Комментарии